| Issue |
E3S Web Conf.
Volume 509, 2024
2nd International Conference on Sustainable Nanotechnology & Nanomaterials (ICONN-2023)
|
|
|---|---|---|
| Article Number | 02008 | |
| Number of page(s) | 15 | |
| Section | Nanobiotechnology and Biological Applications | |
| DOI | https://doi.org/10.1051/e3sconf/202450902008 | |
| Published online | 08 April 2024 | |
Nanotechnology: A promising tool for targeted drug delivery
1 University Institute of Biotechnology, Chandigarh University Mohali
2 Post Graduate Government College-11 Chandigarh
* Corresponding author: pragatikbghs@gmail.com
Nanotechnology has eventually and strongly engaged in the field of drug delivery. It makes use of the specific properties of the substance at the Nano scale. Their primary goal is to increase therapeutic effects while reducing adverse effects. Due to their improved goods, nanotechnology has become more popular across a variety of industries. The term “Nano medicine” is used to denote the application of nanotechnology in medicine. This Nano medicine is essential for drug delivery, antibacterial, vaccine development, wearable technology, diagnostic and imaging tools, implants, high throughput screening platforms, etc. It makes use of biological, biomimetic, no biological, or hybrid materials. To attain logical drug delivery, it is important to understand the interlink age between nanoparticles and the biological environment, drug release, and targeting cell-surface receptors. We can control disease progression by using nanomaterial including peptide-based nanotubes to prey the vascular endothelial growth factor (VEGF) receptor. Also, the use of herbal medicine has been used since ancient times. The supply of active compounds is shown by the effectiveness of various species of herbal medicine. The essential requirements for extending novel nanotechnology-based medication delivery systems are highlighted in this review.
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.